CrystecPharma has been nominated for two awards at this year’s Pharma Industry Awards UK.
Dr. Lyn Daintree, Crystec’s Development Director, has been nominated for the Women in Pharma Award – recognising her outstanding contributions and leadership in the UK pharmaceutical sector. Crystec’s proprietary mSAS® Particle Engineering technology has also been shortlisted for Innovation of the Year, celebrating its impact on the enhanced processing of biomolecules.
The Pharma Industry Awards UK honours the full spectrum of pharma excellence, from R&D and CROs to manufacturing and commercial teams. See the shortlist here: https://pharmaawards.co.uk/shortlist
The awards will take place on September 10th, 2025 at the Park Plaza, London Riverbank.